Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/42996
DC FieldValueLanguage
dc.contributor.authorMetcalf, Daniel J.en_US
dc.contributor.authorGarcía-Arencibia, Moisésen_US
dc.contributor.authorHochfeld, Warren E.en_US
dc.contributor.authorRubinsztein, David C.en_US
dc.contributor.otherGarcia-Arencibia, Moises-
dc.date.accessioned2018-11-21T12:00:56Z-
dc.date.available2018-11-21T12:00:56Z-
dc.date.issued2012en_US
dc.identifier.issn0014-4886en_US
dc.identifier.urihttp://hdl.handle.net/10553/42996-
dc.description.abstractThe accumulation of misfolded proteins in insoluble aggregates within the neuronal cytoplasm is one of the common pathological hallmarks of most adult-onset human neurodegenerative diseases. The clearance of these misfolded proteins may represent a promising therapeutic strategy in these diseases. The two main routes for intracellular protein degradation are the ubiquitin-proteasome and the autophagy-lysosome pathways. In this review, we will focus on the autophagic pathway, by providing some examples of how impairment at different steps in this degradation pathway is related to different neurodegenerative diseases. We will also consider that upregulating autophagy may be useful in the treatment of some of these diseases. Finally, we discuss how antioxidants, which have been considered to be beneficial in neurodegenerative diseases, can block autophagy, thus potentially compromising their therapeutic potential.en_US
dc.languageengen_US
dc.publisher0014-4886-
dc.relation.ispartofExperimental neurologyen_US
dc.sourceExperimental Neurology [ISSN 0014-4886], v. 238, p. 22-28en_US
dc.subject320507 Neurologíaen_US
dc.subject.otherAutophagyen_US
dc.subject.otherNeurodegenerationen_US
dc.subject.otherHuntington's diseaseen_US
dc.titleAutophagy and misfolded proteins in neurodegenerationen_US
dc.typeinfo:eu-repo/semantics/reviewen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.expneurol.2010.11.003en_US
dc.identifier.scopus84866550924-
dc.identifier.isi000309625400003-
dcterms.isPartOfExperimental Neurology-
dcterms.sourceExperimental Neurology[ISSN 0014-4886],v. 238 (1), p. 22-28-
dc.contributor.authorscopusid55756351900-
dc.contributor.authorscopusid15821889300-
dc.contributor.authorscopusid35745995900-
dc.contributor.authorscopusid7006338728-
dc.description.lastpage28en_US
dc.description.firstpage22en_US
dc.relation.volume238en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Reseñaen_US
dc.identifier.wosWOS:000309625400003-
dc.contributor.daisngid2938763-
dc.contributor.daisngid4144634-
dc.contributor.daisngid5008687-
dc.contributor.daisngid37428-
dc.identifier.investigatorRIDK-9920-2013-
dc.utils.revisionen_US
dc.identifier.ulpgcen_US
dc.identifier.ulpgcen_US
dc.identifier.ulpgcen_US
dc.identifier.ulpgcen_US
dc.description.sjr2,124
dc.description.jcr4,645
dc.description.sjrqQ1
dc.description.jcrqQ1
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.orcid0000-0002-1618-4487-
crisitem.author.fullNameGarcía Arencibia, Moisés-
Appears in Collections:Reseña
Show simple item record

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.